Peptide Skincare & BeautySkin science and ingredient guides

Ingredient or product comparison

[GHK-Cu Receptor Pharmacology]: Mechanism Comparison

The following table compares GHK-Cu's receptor-mediated mechanism to other tissue remodeling compounds used in research and clinical settings. The 'Professional Assessment' column provides interpretation of each mechanism's practical implications for lab appli

This source-based comparison does not add ratings or recommend a winner.

  • The following table compares GHK-Cu's receptor-mediated mechanism to other tissue remodeling compounds used in research and clinical settings. The 'Professional Assessment' column provides interpretation of each mechanism's practical implications for lab applications.
  • GHK-Cu
  • Integrin α2β1, α3β1
  • FAK → MAPK/ERK, PI3K/Akt, TGF-β upregulation
  • 100–300 nM (1–3 mg/kg SC)
  • Narrow therapeutic window; effects lost above 10 μM
  • Most versatile for simultaneous collagen synthesis + angiogenesis research; short half-life requires repeated dosing
  • Copper sulfate
  • Nonspecific plasma protein binding (albumin, ceruloplasmin)
  • Copper-dependent enzyme activation (lysyl oxidase, SOD)
  • 15–25 μM (nutritional doses)
  • No receptor specificity; requires 1000× higher concentration than GHK-Cu for equivalent collagen effects
  • Useful only as a negative control or baseline copper source; lacks targeted signaling
  • TGF-β1 recombinant
  • TGF-β receptor I/II heterodimer
  • Smad2/3 phosphorylation → nuclear translocation
  • 1–10 ng/mL (exogenous)
  • Drives fibrosis without MMP balance; no angiogenic component
  • Gold standard for fibroblast activation but pro-scarring profile limits translational relevance
  • VEGF-A (vascular endothelial growth factor)
  • VEGFR-2 (KDR/Flk-1)
  • PI3K/Akt, PLC-γ → endothelial proliferation, permeability
  • 50–200 pg/mL (endogenous; exogenous dosing variable)
  • Pure angiogenesis without matrix remodeling; causes vascular leak at high doses
  • Ideal for angiogenesis-only studies; must be combined with ECM modulators for wound healing models
  • Tretinoin (all-trans retinoic acid)
  • Retinoic acid receptor (RAR-α, β, γ)
  • Gene transcription via retinoic acid response elements (RAREs)
  • Not systemically dosed (topical)
  • Irritation limits dosing; collagen synthesis offset by increased MMP-1 in some contexts
  • Clinical standard for photoaging but mechanism is transcriptional (slow onset) vs. GHK-Cu's receptor-mediated (rapid)